Still no response to emails sent. This week would be a very good time to come out and reassure investors.
He needs to give an indication as to what is taking place within the FDA. There is no way he had no contact with them for this long.
Either approval and productio or more questions and wait another 8 months for it to go.
The .21 share sale can be a good or a bad thing. Good because we need the operating capital as the sale of Refurbished C Arms is down. It is also bad because as others have pointed out it can be an indication that this appeoval is a long ways away from being completed.
Giving up close to 5,000,000 shares at .21 a share is extremely undervalued or overvalued depending on the information out there. If Dean has verbal approval and borrowed money to keep the lights on, that's a bad move. Due to the amount of money given away!
But if he KNOWS there are problems and needs MORE time and signed personal guarantees to secure the loan, then it would make more sense but still not happy with it until we get more info.
Market Data 
Markets 
